ClinicalTrials.Veeva

Menu

Retrospective Data Collection on the Use of Motiva Flora TE in Breast Reconstruction

E

Establishment Labs

Status

Completed

Conditions

Breast Cancer

Treatments

Device: Motiva Flora TE

Study type

Observational

Funder types

Industry

Identifiers

NCT05459064
CLINP-001013

Details and patient eligibility

About

The Motiva Flora® TE are intended for temporary subcutaneous or submuscular implantation to develop surgical flaps and additional tissue coverage and are not intended for use beyond six (6) months.

All Motiva Flora® TE's require periodic, incremental inflation with sterile saline for injection until the desired tissue amount is developed. After the desired volume, the expander is surgically removed and replaced with a long-term breast implant in the same space as the tissue expander.

The study collects retrospective data on the use of the Motiva Flora TE, from patients who had a tissue expander-based-breast reconstruction using the Motiva Flora® TE since market introduction in May 2020.

Enrollment

144 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient has completed a tissue expander-based breast reconstruction with the Motiva Flora® TE .
  • Patient has been informed correctly according to to the applicable national and local regulations.

Exclusion criteria

  • Not applicable

Trial contacts and locations

2

Loading...

Central trial contact

Catalina Solano; Carin Nilsson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems